Conference Activities & Talks -

61. 倉上真樹、小早川拓也、横山勝、村上努、金子萌美、小谷治、佐藤裕徳、玉村啓和. HIV-1 カプシドタンパク質の構造を基にした新規抗HIV-1 剤の構造活性相関研究. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

62. 東知佳、小早川拓也、玉村啓和. ペプチドミメティックを指向したクロロアルケン型ジペプチドイソスターの合成研究. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

63. 海老原健人、川田拓馬、小早川拓也、村上努、玉村啓和. HIV-1 膜融合を標的とする低分子化合物を基にした二価型膜融合阻害剤の創製. 第37回メディシナルケミストリーシンポジウム 2019.11.27 東京

64. Elucidation of mechanism of HIV-1 fusion inhibitors developed by dimerization strategy. 第67回 日本ウイルス学会学術集会 2019.10.29 東京

65. 松田幸樹、小早川拓也、土屋亮人、服部真一朗、潟永博之、吉村和久、岡慎一、遠藤泰之、玉村啓和、満屋裕明、前田賢次. HIV潜伏感染再活性化を介してリザーバー細胞にアポトーシスを誘導するPKC活性化剤の同定. 第67回 日本ウイルス学会学術集会 2019.10.29

66. Wataru Nomura, Takumi Kamimura, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic ZIP tag-probe system for fluorescent imaging of endogenous protein expression. 第56回ペプチド討論会 2019.10.25

67. Rongyi Wang, Takuya Kobayakawa, Moemi Kaneko, Kofi Owusu, Tsutomu Murakami, Hirokazu Tamamura. Development of cell-permeable anti-HIV peptides based on capsid proteins. 第56回ペプチド討論会 2019.10.25

68. Maxwell M. Sakyiamah, Wataru Nomura, Takuya Kobayakawa, Hirokazu Tamamura. Development of a nanoBRET-based sensitive screening method to search for chemokine receptor CXCR4 ligands. 第56回ペプチド討論会 2019.10.25 東京

69. Yuki Watanabe, Takuya Kobayakawa, Atsuhiko Taniguchi, Yoshio Hayashi, Hirokazu Tamamura. Development of peptidomimetic inhibitors for aggregation of amyloid beta. 2019.10.23 東京

70. Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. Development of HIV-1 fusion inhibitors based on the C34 dimer derived from an HIV-1 envelope protein gp41. 第56回ペプチド討論会 2019.10.23 東京

71. Masaki Kurakami, Takuya Kobayakawa, Masaru Yokoyama, Tsutomu Murakami, Moemi Kaneko, Osamu Kotani, Hironori Sato, Hirokazu Tamamura. Structure-activity relationship studies of small molecular anti-HIV-1 compounds targeting a dipeptide site of HIV-1 capsid proteins. 第56回ペプチド討論会 2019.10.23 東京

72. Takuya Kobayakawa, Hirokazu Tamamura. Development of chemical synthesis for peptidomimetic based on a chloroalkene dipeptide isostere and its application to a cyclic peptide. 第56回ペプチド討論会 2019.10.23 東京

73. Hirokazu Tamamura. Elucidation of a dimerization state of a GPCR and its application to molecular probes for cancer cells. The 2019 International Conference on Molecular Imaging and Minimally Invasive Therapy (2019 MIMIT) 2019.10.18 Beijing, China

74. Hirokazu Tamamura. Development of bivalent ligands of GPCR and their application to molecular probes for cancer cells and anti-cancer agents. 7th Modern Solid Phase Synthesis & Its Applications Symposium 2019.09.07 Palm Cove, Australia

75. Tamamura H. Peptide drug discovery. 25th Peptide Forum – International Forum on Peptides in Drug Discovery - /Satellite Symposium of 10th International Peptide Symposium 2018.12.10 Tokyo, Japan

76. Wataru Nomura , Takumi Kamimura, Daisuke Matsumoto, Takuya Kobayakawa, Hirokazu Tamamura. Fluorogenic and genetically encodable tag-probe system for in-cell imaging of protein synthesis . 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.05 Kyoto, Japan

77. 小早川 拓也, 玉村 啓和. Synthetic Strategy of Peptidomimetic Based on Chloroalkene Dipeptide Isoteres and Its Biological Application. 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.03 Kyoto, Japan

78. Tamamura H. Peptidomimetic-based mid-size drugs: anti-cancer and anti-HIV agents. 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.03 Kyoto, Japan

79. Kento Ebihara, Yuzuna Honda, Takuya Kobayakawa, Tsutomu Murakami, Hirokazu Tamamura. HIV-1 Fusion Inhibitors Based on gp41-C34 dimers. 10th International Peptide Symposium／55th Japanese Peptide Symposium 2018.12.03 Kyoto, Japan

80. Takuya Kobayakawa, Kohei Takahashi, Ami Masuda, Shigeyoshi Harada, Tomoyuki Miura, Shuzo Matsushita, Kazuhisa Yoshimura, Hirokazu Tamamura. Structure‐activity relationship studies of CD4 mimic molecules for targeting an envelope protein gp120 on HIV-1. 19th Kumamoto AIDS Seminar 2018.11.06 Kumamoto, Japan